Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

58.44
Delayed Data
As of Jan 16
 -0.40 / -0.68%
Today’s Change
39.25
Today|||52-Week Range
59.60
+2.40%
Year-to-Date

Today’s Trading

Previous close58.84
Today’s open58.89
Day’s range58.23 - 59.14
Volume7,175,001
Average volume (3 months)5,973,133
Market cap$102.4B
Data as of 4:02pm ET, 01/16/2018

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+13.57%
Earnings growth (next 5 years)+12.13%
Revenue growth (last year)+2.20%
P/E ratio48.7
Price/Sales2.73
Price/Book4.22

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-1.69-1.94%
NVONovo Nordisk+0.27+0.49%
BMYBristol-Myers Squibb-2.89-4.60%
GSKGlaxoSmithKline+0.42+1.12%
Data as of 4:02pm ET, 01/16/2018

Financials

Next reporting dateJanuary 24, 2018
EPS forecast (this quarter)$0.73
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts